We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Regarding manufacture of PET drug 13N NH3, a USP monograph drug which is used for diagnostic purposes and not under IND or RDRC review: No formal process validation or verification (min. three consecutive batches) has been performed.